Notices. Notice
1,282 words·~6 min read·
/register/2006/09/11/06-7574A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4150-24-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) announces the following Federal Committee meeting. *Name:* Advisory Committee on Immunization Practices (ACIP). *Times and Dates:* October 25, 2006, 8 a.m.-6 p.m., October 26, 2006, 8 a.m.-4 p.m. *Place:* Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Global Communications Center, Room 232, Atlanta, Georgia 30333. *Status:* Open to the public, limited only by space available.
The meeting space accommodates approximately 330 people. Overflow space for real-time viewing will be available. *Purpose:* The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children
(VFC)program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. *Matters to be Discussed:* The agenda will include discussions on immunization safety, vaccine financing, herpes zoster (shingles) vaccine, rabies vaccine, meningococcal vaccine (MCV4), influenza vaccine, human papillomavirus vaccine follow-up, evidence-based methods for development of ACIP recommendations, and agency updates. Agenda items are subject to change as priorities dictate. *Additional Information:* In order to expedite the security clearance process at the CDC Roybal Campus on Clifton Road, all ACIP attendees are required to register on-line at *http://www.cdc.gov/nip/acip.* Registration instructions and forms can be found under the “Upcoming Meetings” tab. Please be sure to complete all the required fields before submitting your registration and submit no later than September 29, 2006. Please Note: All non-U.S. citizens must pre-register by September 29, 2006. Access will not be allowed to the campus and registration will *NOT* be allowed on site at the time of the meeting. All non-U.S. citizens are required to complete the “Access Request Form” and register on-line at *http://www.cdc.gov/nip/acip.* The access request form can be obtained from the ACIP Web site and should be e-mailed directly back to Ms. Demetria Gardner at *dgardner@cdc.gov* upon completion. *For Further Information Contact:* Demetria Gardner, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta, Georgia 30333, telephone 404/639-8836, fax 404/639-8905. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Dated: September 1, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6-14949 Filed 9-8-06; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS-5043-N] RIN 0938-ZA90 Physician-Hospital Collaboration Demonstration AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. SUMMARY: This notice is to inform interested parties of an opportunity to apply to participate in a demonstration under section 646 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), the Medicare Health Care Quality Demonstration, to examine the effects of gainsharing aimed at improving the quality of care in a health delivery system. More specifically, the demonstration will determine if gainsharing is an effective means of aligning financial incentives to enhance quality and efficiency of care across an entire system of care. In contrast to traditional models of gainsharing, which focus on the inpatient stay, this demonstration will examine approaches that involve long-term follow-up to assure both documented improvements in quality and reductions in the overall costs of care. Projects must also be of sufficient size to ensure statistical robustness of the results. CMS is particularly interested in demonstration designs that track patients well beyond a hospital episode, to determine the impact of hospital-physician collaborations on preventing short- and longer-term complications, duplication of services, coordination of care across settings, and other quality improvements that hold great promise for eliminating preventable complications and unnecessary costs. From the perspective of implementing and evaluating the demonstration, we also require some standardization of gainsharing approaches, physician payments, and hospital savings measurement across sites. Therefore, for the Section 646 Gainsharing Demonstration, CMS will operate projects submitted by consortia, comprising of health care groups and their affiliated hospitals. A limited number of projects will be operated in various geographic areas; no more than 72 hospitals can be included across all projects. DATES: Applications for the demonstration under MMA section 646 will be considered timely if we receive them no later than 5 p.m., Eastern Standard Time (e.s.t.), on January 9, 2007. FOR FURTHER INFORMATION CONTACT: Lisa Waters at
(410)786-6615 or *GAINSHARING@cms.hhs.gov.* Interested parties can obtain a complete solicitation, application, and supporting information on the following CMS Web sites at *http://www.cms.hhs.gov/DemoProjectsEvalRpts/MD/itemdetail.asp?filterType=none&filterByDID=-99&sortByDID=3&sortOrder= ascending&itemID=CMS1186653.* Paper copies can be obtained by writing to Lisa Waters at the address listed in the ADDRESSES section of this notice. ADDRESSES: Mail or deliver applications to the following address: Centers for Medicare & Medicaid Services, Attention: Lisa Waters, Mail Stop: C4-17-27, 7500 Security Boulevard, Baltimore, Maryland 21244. Because of staff and resource limitations, we cannot accept applications by facsimile
(FAX)transmission or by e-mail. *Eligible Organizations for MMA 646:* As stipulated in the enabling legislation, physician groups, integrated delivery systems, or an organization representing regional coalitions of physician groups or integrated delivery systems are eligible to apply. A comprehensive list of all eligibility requirements can be found in the “Eligible Organizations” section of the solicitation. We envision projects that seek to improve quality and efficiency in several areas of each participating organization. SUPPLEMENTARY INFORMATION: I. Background Section 646 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
(MMA)(Pub. L. 108-173) amends title XVIII (42 U.S.C. 1395 *et seq.* ) of the Social Security Act to establish the Medicare Health Care Quality
(MHCQ)Demonstration Programs. The MHCQ demonstration will test major changes to improve quality of care while increasing efficiency across an entire health care system. Broadly stated, the goals of the Medicare Health Care Quality demonstration are to: • Improve patient safety; • Enhance quality of care by increasing efficiency; and • Reduce scientific uncertainty and the unwarranted variation in medical practice that results in both lower quality and higher costs. II. Provisions of the Notice This notice solicits applications to participate in the MMA Section 646 Medicare Hospital Gainsharing Demonstration that will assist in determining if gainsharing can align incentives between hospitals and physicians to improve the quality and efficiency of care provided to beneficiaries over episodes of care and across settings. The focus of each demonstration will be to link physician incentive payments to improvements in quality and efficiency. This demonstration will provide measures to ensure that the quality and efficiency of care provided to beneficiaries is monitored and improved. We envision projects that seek to improve quality and efficiency in several areas of each participating organization. Overall, we seek demonstration models that result in savings to Medicare. We will assure this 3-year demonstration is budget neutral. III. Collection of Information Requirements This information collection requirement is subject to the Paperwork Reduction Act of 1995 (PRA); however, the collection is currently approved under OMB control number 0938-0880 entitled “Medicare Demonstration Waiver Application.” Authority: Section 646 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Public Law 108-173. (Catalog of Federal Domestic Assistance Program No. 93.778, Medical Assistance Program; No. 93.773 Medicare—Hospital Insurance Program; and No. 93.774, Medicare—Supplementary Medical Insurance Program) Dated: August 7, 2006. Mark B. McClellan, Administrator , Centers for Medicare & Medicaid Services. [FR Doc. 06-7574 Filed 9-6-06; 1:59 pm]
Connectionstraces to 2
Traces to 2 documents
2 references not yet in our index
- Pub. L. 92-463
- Pub. L. 108-173
Citation graph
cites case law
Cites 4Cited by 0 across 0 sources